Lowest Price Guaranteed From USD 4,799
Published
February 2023
Pages
387
View Count
74562
Example Insights
Please scroll down
Report Description
In terms of internal rate of return (IRR), modular manufacturing facilities are less expensive than stick-built facilities, with an IRR of 11% versus 8% for stick-built facilities. This provides an excellent opportunity for business partners to optimize project costs
-- CEO, a US-based mid-sized company
The global modular construction market is estimated to be worth $2.5 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 9.9% during the forecast period. The adoption of modular facilities is growing in the pharmaceutical industry and the modular construction market is anticipated to grow at a CAGR of 10% during the forecast period. In the past few years, modular facilities or prefabricated buildings have emerged as a promising alternative to the conventionally built pharma / biotech manufacturing facilities. Modular construction involves building of structures using prefabricated modular units, off-site, under controlled factory setting, which are later assembled on site. It is interesting to note that off-site construction can eliminate 60%-90% of the weather-related project concerns. Further, modular facilities can be built 40% faster, as compared to a conventional construction, which could take up to three years. Therefore, considering the various advantages offered by this approach, several pharmaceutical companies are now shifting their focus from conventional plants to modular facilities. Specifically, modular facility providers are catering to the needs of various players engaged in the development of therapeutics, including cell and gene therapy, biosimilars and vaccines. To provide more context, modular manufacturing includes division of individual production processes, such as fermentation, purification and formulation, into separate modules that can be easily assembled and disassembled, allowing for flexibility and scalability. In addition, modular manufacturing allows the use of smaller-scale production units, which can be more flexible and responsive to dynamic market demands. Moreover, temporary modular buildings can be relocated after installation, based on needs of the end-user. However, mass production, complex decision-making, construction approvals and early financing can hinder the adoption of modular constructs. If healthcare stakeholders are able to overcome these challenges, modular construction can serve as a lucrative approach that provides greater flexibility and enables faster time-to-market for new products.
![]() |
The Modular Construction Market for Biotechnology and Pharmaceutical Industry (3rd Edition), 2023-2035: Distribution by Size of Facility (Small, Mid-sized, Large and Very Large), Type of Industry Served (Pharmaceutical and Biotechnology), Type of Modular Construct (Hybrid Skid Modular Constructs, Skid-Mounted Modular Constructs, Plug-and-Play Modular Constructs, Truckable Modular Constructs and Other Modular Constructs), Type of Construction Component (Process Equipment, Base Building, Mechanical, Electrical and Plumbing System, Process Commodities and Other Construction Components), Purpose of Facility (Manufacturing Facilities, Aseptic Filling Facilities, Research and Development Facilities and Other Facilities), Scale of Operation (Clinical and Commercial), Type of Product (Cell and Gene Therapies, Vaccines, Biosimilars, Monoclonal Antibodies, Advanced Pharmaceuticals, Sterile Products, Viral Vectors and Other Products), Type of Expansion (New Facilities, Facility Expansions and Planned Expansions), Type of Modular Construction (Relocatable Modular Construction, Permanent Modular Construction), Type of Material Used (Steel, Wood and Concrete) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape, market size and future opportunity, offering an informed opinion on the likely adoption of modular manufacturing in the biotechnology / pharmaceutical industry, over the forecast period. The market report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry. The research report answers the following key questions related to the biopharmaceutical modular manufacturing market.
![]() |
Modular facilities have emerged as a promising alternative to conventional facilities owing to the multiple benefits that they offer. For instance, modular facilities can help in achieving 25%-30% reduction in the overall cost of construction, minimal plant site interruption, 50%-60% faster construction timelines, as well as ensure portability, safe working conditions and sustainability. In addition, better quality of products can be achieved by modular construction approaches as the modules are built in a controlled factory setting. In addition, these modules are inspected more thoroughly and frequently before they are shipped to the construction site, meeting desired quality standards. Moreover, modular construction allows more flexibility in terms of design, as a higher number of materials and finishes can be used, as compared to conventional facilities.
![]() |
The modular construction market landscape features an extensive list of over 50 large, mid-sized, small and very small manufacturers. It is worth highlighting that there are more than 250 modular cleanroom manufacturers, offering various cleanroom accessories and customization options, in order to make them suitable for application in the life sciences industry. It is expected that modular manufacturing will become more streamlined and standardized in the future, serving as an efficient cost saving solution. Additionally, modular techniques allow building of smaller and specialized processing plants whenever rapid deployment of a therapy becomes critical in both developed and developing countries. Further, many, if not most, expansions and new facilities in the biotechnology and pharmaceutical industry are likely to be modular construction in the near future.
![]() |
Over the past few years, several factors have contributed to reform the facility construction paradigm within the pharmaceutical and biotechnology industries. The increasing preference and demand for personalized therapies and novel therapeutic interventions intended for the treatment of various ailments has compelled pharmaceutical companies to look beyond the traditional manufacturing and expansion practices. Lack of adequate manufacturing infrastructure, increased cost of construction and delay in project deliveries has collectively contributed to the emergence of off-site construction models. In addition, the increased demand for vaccine manufacturing during the COVID-19 pandemic also proved to be a key growth driver for adoption of the modular clean room / prefabricated cleanrooms. In March 2021. G-CON Manufacturing delivered its prefabricated cleanroom PODs to Fujifilm Diosynth Biotechnologies for expansion of COVID-19 vaccine manufacturing at its College Station, Texas facility. Another China based modular facility manufacturer, Pharmadule Morimatsu AB delivered a modular vaccine manufacturing plant in Morocco. Funded by the Moroccan government, the plant was set up to increase the local production of vaccines. Even the growing cell and gene therapy market is adopting modular manufacturing. In May 2022, G-CON Manufacturing supplied prefabricated cleanrooms to Puerto Rico facility of CytoImmune for clinical manufacturing of NK cell-based therapies. Over the forecast period, the modular construction market for biotechnology and pharmaceutical industry is likely to grow at a healthy CAGR, as the drug manufacturers realize the benefits offered by modular manufacturing of drug facilities.
![]() |
Driven by the rising interest of stakeholders towards improvement of manufacturing and production efficiency, the anticipated lucrative opportunities and growth associated with the adoption of modular facilities, the modular manufacturing market for pharmaceutical industry is expected to witness noteworthy market growth during the forecast period. Specifically, in terms of type of product, the market is anticipated to be driven by manufacturing units for cell and gene therapies, as well as vaccines and biosimilars. In addition, presently, close to 70% of the market share is captured by facility manufacturers based in North America and Europe. However, in the long run, markets in emerging regions, such as countries based in Asia, MENA and rest of the world are anticipated to grow at a faster pace.
![]() |
Examples of key companies engaged in this industry (which have also been profiled in this market report) include (in alphabetical order) Cytiva, G-Con Manufacturing, Germfree, IPM Technologies, KeyPlants, ModuleCo Pharma, NNE and Pharmadule. The report includes an easily searchable excel database of all the modular facility and modular clean room manufacturers serving the biotechnology / pharmaceutical industry worldwide.
![]() |
Several recent developments have taken place in the field of modular construction. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.
The market report presents an in-depth analysis of the various firms / organizations that are engaged in this industry, across different segments, as defined in the table below:
Report Attribute | Details | |
Base Year |
2022 |
|
Forecast Period |
2023 – 2035 |
|
CAGR |
10% |
|
Size of Facility |
Small, Mid-sized, Large and Very Large |
|
Type of Construction Component |
Process Equipment, Base Building, Mechanical, Electrical and Plumbing System, Process Commodities and Other Construction Components | |
Type of Facility |
Manufacturing Facilities, Aseptic Filling Facilities, Research and Development Facilities, and Other Facilities | |
Scale of Operation |
Clinical and Commercial |
|
Type of Industry Served |
Pharmaceutical and Biotechnology | |
Type of Product | Cell and Gene Therapies, Vaccines, Biosimilars, Monoclonal Antibodies, Advanced Pharmaceuticals, Sterile Products, Viral Vectors and Other Products | |
Type of Facility | New Facilities, Facility Expansions and Planned Expansions | |
Type of Modular Construction | Permanent and Relocatable | |
Type of Material Used | Steel, Wood and Concrete | |
Key Geographical Regions | North America, Europe, Asia-Pacific, MENA and Rest of the World | |
Customization Scope | 15% Free Customization Option | |
PowerPoint Presentation (Complimentary) | Available | |
Excel Data Packs (Complimentary) | Market Landscape Analysis, Modular Cleanroom Manufacturers Analysis, Company Competitiveness Analysis, Partnership and Collaboration Analysis, Case Study on Modular Projects Analysis, Facility Construction Trends Analysis and Market Forecast and Opportunity Analysis |
![]() |
The market report features an in-depth market analysis, highlighting the capabilities of various stakeholders engaged in this market. Amongst other elements, the research report includes:
![]() |
The opinions and insights presented in the market report were influenced by discussions held with senior stakeholders in the industry. The market research report features detailed transcripts of interviews held with the following industry stakeholders:
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market report are in USD, unless otherwise specified.
![]() |
Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Historical Background
3.3. The Concept of Modular Facilities
3.3.1. Types of Modular Constructs
3.3.2. Modular Construction Process
3.4. Modular Construction in the Pharmaceutical Industry
3.4.1. Advantages of Modular Construction in the Pharmaceutical Industry
3.4.2. Modular Pharmaceutical Cleanrooms
3.4.2.1. Cleanroom Classifications and Current Standards
3.4.2.2. Regulations and Standards Concerning Modular Cleanroom Construction
3.5. Advantages of Modular Cleanrooms
3.6. Challenges and Future Prospects
4. MARKET LANDSCAPE: MODULAR FACILITY MANUFACTURERS
4.1. Chapter Overview
4.2. Modular Facility Manufacturers: Overall Market Landscape
4.2.1 Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Year of Establishment and Location of Headquarters
4.2.5. Analysis by Company Size and Location of Headquarters
4.2.6. Analysis by Type of Industry Served
4.2.7. Analysis by Geographical Coverage
4.2.8. Analysis by Type of Industry Served and Geographical Coverage
4.2.9. Analysis by GMP Compliance
4.2.10. Analysis by Geographical Coverage and GMP Compliance
4.2.11. Analysis by Type of Modular Construction
4.2.12. Analysis by Type of Industry Served and Type of Modular Construction
4.2.13. Analysis by Type of Material Used
4.2.14. Analysis by Type of Modular Construction and Type of Material Used
4.2.15. Analysis of Historical and Current Market Landscape Trends
4.2.15.1 Analysis by Company Size, Geographical Coverage and Type of Industry Served
5. MARKET LANDSCAPE: MODULAR CLEANROOM MANUFACTURERS
5.1. Chapter Overview
5.2. Modular Cleanroom Manufacturers: Overall Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Location of Headquarters
5.2.4. Analysis by Year of Establishment and Location of Headquarters
5.2.5. Analysis by Company Size and Location of Headquarters
5.2.6. Analysis by Type of Industry Served
5.2.7. Analysis by Location of Headquarters and Type of Industry Served
5.2.8. Analysis by Type of Modular Cleanroom Offered
5.2.9. Analysis by Type of Industry Served and Type of Modular Cleanroom Offered
5.2.10. Analysis by Type of Cleanroom Component Offered
5.2.11. Analysis by Type of Industry Served and Cleanroom Component Offered
5.2.12. Analysis by Type of Modular Cleanroom and Cleanroom Component Offered
5.2.13. Analysis by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
5.2.14. Analysis by Quality Certifications Obtained
6. MODULAR FACILITY MANUFACTURERS: COMPANY COMPETITIVENESS ANALYSIS
6.1 Chapter Overview
6.2 Assumptions / Key Parameters
6.3 Methodology
6.4 Company Competitiveness Analysis: Modular Facility Manufacturers
6.4.1. Company Competitiveness Analysis: Benchmarking of Service Strength
6.4.2. Company Competitiveness Analysis: Benchmarking of Partnership activity
6.4.3. Company Competitiveness Analysis: Small Companies
6.4.4. Company Competitiveness Analysis: Mid-Sized Companies
6.4.5. Company Competitiveness Analysis: Large Companies
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Cytiva
7.2.1. Company Overview
7.2.2. Modular Facility-related Services
7.2.3. Modular Projects
7.2.4. Recent Developments and Future Outlook
7.3. G-Con Manufacturing
7.3.1. Company Overview
7.3.2. Modular Facility-related Services
7.3.3. Modular Projects
7.3.4. Recent Developments and Future Outlook
7.4. Germfree
7.4.1. Company Overview
7.4.2. Modular Facility-related Services
7.4.3. Modular Projects
7.4.4. Recent Developments and Future Outlook
7.5. IPM Technologies
7.5.1. Company Overview
7.5.2. Modular Facility-related Services
7.5.3. Modular Projects
7.5.4. Recent Developments and Future Outlook
7.6. KeyPlants
7.6.1. Company Overview
7.6.2. Modular Facility-related Services
7.6.3. Modular Projects
7.6.4. Recent Developments and Future Outlook
7.7. ModuleCo Pharma
7.7.1. Company Overview
7.7.2. Modular Facility-related Services
7.7.3. Modular Projects
7.7.4. Recent Developments and Future Outlook
7.8. NNE
7.8.1. Company Overview
7.8.2. Modular Facility-related Services
7.8.3. Modular Projects
7.8.4. Recent Developments and Future Outlook
7.9. Pharmadule
7.9.1. Company Overview
7.9.2. Modular Facility-related Services
7.9.3. Modular Projects
7.9.4. Recent Developments and Future Outlook
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Modular Facility Manufacturers: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year of Partnership and Type of Partnership
8.3.4. Analysis by Type of Product
8.3.5. Analysis by Type of Partnership and Type of Product
8.3.6. Analysis by Type of Modular Facility
8.3.7. Analysis by Type of Product and Type of Modular Facility
8.3.8. Most Active Players: Analysis by Number of Partnerships
8.3.9. Analysis by Location of Partner’s Headquarters
8.3.10. Analysis by Location of Modular Facility
8.3.11. Analysis by Type of Partnership and Location of Modular Facility
8.3.12. Analysis by Type of Product and Location of Modular Facility
8.3.13. Intercontinental and Intracontinental Partnerships
8.3.14. Analysis by Country
9. CASE STUDY ON MODULAR PROJECTS IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
9.1. Chapter Overview
9.2. Modular Versus Conventional Construction Methods
9.3. Return on Investment
9.4. Case Study: Facility Based on KUBio Platform
9.4.1. Cytiva KUBio Platform: Overview
9.4.2. Eden Biologics Kubio Modular Project in China: Overview and Construction Details
9.5. Modular Facility Projects Undertaken in the Pharmaceutical and Biotechnology Industry
9.5.1. Analysis by Type of Modular Facility
9.5.2. Analysis by Size of Modular Facility
9.5.3. Most Active Manufacturers: Analysis by Number of Projects Delivered
9.5.4. Leading Clients: Analysis by Number of Projects Received
9.5.5. Analysis by Location of Modular Facility
9.5.6. Analysis by Type of Facility and Size of Modular Facility
9.5.7. Analysis by Client and Location of Facility
10. FACILITY CONSTRUCTION TRENDS IN THE PHARMACEUTICAL INDUSTRY
10.1. Chapter Overview
10.2. Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry: Historical Data for Top 20 Players
10.2.1. Analysis by Number of Facilities Delivered
10.2.2. Analysis by Type of Facility
10.2.3. Analysis by Purpose of Facility
10.2.4. Analysis by Type of Facility and Purpose of Facility
10.2.5. Analysis by Type of Investment
10.2.6. Analysis by Purpose of Facility and Type of Investment
10.2.7. Analysis by Size of Facility
10.2.8. Analysis by Type of Facility and Size of Facility
10.2.9. Analysis by Purpose of Facility and Size of Facility
10.2.10. Analysis by Location of Headquarters
10.2.11. Analysis by Location of Facility
10.2.12. Analysis by Type of Facility and Location of Facility
11. COST-TIME OPTIMIZATION FRAMEWORK
11.1. Chapter Overview
11.2. Key Parameters
11.3. Key Assumptions and Methodology
11.4. Comparison of Intrinsic Factors
11.4.1. Analysis by Type of Material Used
11.4.2. Analysis by Type of Modular Construction
11.4.1. Analysis by Purpose of Facility
11.4.2. Analysis by Geographical Location
11.5. Integrated Outcome Modeling – Scenario Analysis
11.6. Integrated Outcome Modeling – Output Analysis
11.7. Concluding Remarks
12. MARKET FORECAST
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Modular Construction Market in the Pharmaceutical / Biotechnology Sector, 2023-2035
12.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Size of Facility, 2023 and 2035
12.4.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Small Facilities, 2023-203
12.4.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mid-sized Facilities, 2023-2035
12.4.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Large Facilities, 2023-2035
12.4.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Very Large Facilities, 2023-2035
12.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Industry Served, 2023 and 2035
12.5.1. Modular Construction Market in the Pharmaceutical Industry, 2023-2035
12.5.2. Modular Construction Market in the Biotechnology Industry, 2023-2035
12.6. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Modular Construct, 2023 and 2035
12.6.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Hybrid Skid Modular Constructs, 2023-2035
12.6.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Skid-Mounted Modular Constructs, 2023-2035
12.6.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Plug-and-Play Modular Constructs, 2023-2035
12.6.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Truckable Modular Constructs, 2023-2035
12.6.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Modular Constructs, 2023-2035
12.7. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Construction Component, 2023 and 2035
12.7.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Equipment, 2023-2035
12.7.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Base Buildings, 2023-2035
12.7.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mechanical, Electrical and Plumbing Systems, 2023-2035
12.7.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Commodities, 2023-2035
12.7.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Construction Components, 2023-2035
12.8 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Purpose of Facility, 2023 and 2035
12.8.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Manufacturing, 2023-2035
12.8.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Aseptic Filling, 2023-2035
12.8.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Research and Development, 2023-2035
12.8.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Purposes, 2023-2035
12.9. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Scale of Operation, 2023 and 2035
12.9.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Clinical Scale, 2023-2035
12.9.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Commercial Scale, 2023-2035
12.10. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Product, 2023 and 2035
12.10.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Cell and Gene Therapies, 2023-2035
12.10.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Vaccines, 2023-2035
12.10.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Biosimilars, 2023-2035
12.10.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Monoclonal Antibodies, 2023-2035
12.10.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Advanced Pharmaceuticals, 2023-2035
12.10.6. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Sterile Products, 2023-2035
12.10.7. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Viral Vectors, 2023-2035
12.10.8. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Products, 2023-2035
12.11. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Facility, 2023 and 2035
12.11.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for New Facilities, 2023-2035
12.11.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Facility Expansions, 2023-2035
12.11.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Planned Expansions, 2023-2035
12.12. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Modular Construction, 2023 and 2035
12.12.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Relocatable Modular Construction, 2023-2035
12.12.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Permanent Modular Construction, 2023-2035
12.13. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Material Used, 2023 and 2035
12.13.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Steel, 2023-2035
12.13.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Wood, 2023-2035
12.13.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Concrete, 2023-2035
12.14. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Geography, 2023 and 2035
12.14.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in North America, 2023-2035
12.14.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Europe, 2023-2035
12.14.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Asia, 2023-2035
12.14.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Middle East and North Africa, 2023-2035
12.14.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Rest of the World, 2023-2035
12.15. Concluding Remarks
13. PREVALENT AND EMERGING INDUSTRY TRENDS
13.1. Chapter Overview
13.2. Adoption of Modular Facilities
13.3. Expansion of Existing Service Portfolio
13.4. Integration of Advanced Technologies
13.4.1. Single-use Technologies
13.4.2. Continuous Processing Technologies
13.4.3. Other Advanced Technologies
14. FUTURE GROWTH OPPORTUNITIES
14.1. Chapter Overview
14.2. Visibility Amongst Start-Ups
14.3. Popularity Amongst Contract Manufacturing Organizations
14.4. Expansion of Existing Facilities
14.5. Adoption for Production of Biosimilars
14.6. Additional Opportunities
14.7. Key Growth Drivers for Modular Construction
14.8. Market Attractiveness in Emerging regions
15. CONCLUSION
16. EXECUTIVE INSIGHTS
16.1. Chapter Overview
16.2. Avon Modular
16.2.1. Company Snapshot
16.2.2. Interview Transcript: Alan de Zayas (Modular Building Manufacturing and Construction Team)
16.3. Environmental Systems Corporation
16.3.1. Company Snapshot
16.3.2. Interview Transcript: Vernon Solomon (President)
16.4. Exyte
16.4.1. Company Snapshot
16.4.2. Interview Transcript: François Abiven (Executive Vice President Global Business Unit BLS) and Luca Mussati (Vice President Technology and Innovation)
16.5. G-Con Manufacturing
16.5.1. Company Snapshot
16.5.2. Interview Transcript: Maik Jornitz (Chief Executive Officer)
16.6. Modular Devices
16.6.1. Company Snapshot
16.6.2. Interview Transcript: Mark Koers (Executive Vice President, Sales and Marketing)
16.7. ModWave
16.7.1. Company Snapshot
16.7.2. Interview Transcript: Pär Almhem (President)
16.8. Subzero Engineering
16.8.1. Company Snapshot
16.8.2. Interview Transcript: Ward Patton (Director of Sales)
16.9. Vernick
16.9.1. Company Snapshot
16.9.2. Interview Transcript: Wes Temple (Director of Marketing)
16.10. Zeton
16.10.1. Company Snapshot
16.10.2. Interview Transcript: Sulogna Roy (Ex-Sales Manager)
17. APPENDIX I: TABULATED DATA
18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1 Executive Summary: Modular Facility Manufacturers
Figure 2.2 Executive Summary: Modular Cleanroom Manufacturers
Figure 2.3 Executive Summary: Partnerships and Collaborations
Figure 2.4 Executive Summary: Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry
Figure 2.5 Executive Summary: Facility Construction Trends in the Pharmaceutical Industry
Figure 2.6 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Modular Construction: Applications
Figure 3.2 Modular Construction: Processes Involved
Figure 3.3 Modular and Conventional Buildings: Construction Timeline
Figure 3.4 Modular Construction: Advantages
Figure 4.1 Modular Facility Manufacturers: Distribution by Year of Establishment
Figure 4.2 Modular Facility Manufacturers: Distribution by Company Size
Figure 4.3 Modular Facility Manufacturers: Distribution by Location of Headquarters
Figure 4.4 Modular Facility Manufacturers: Distribution by Year of Establishment and Location of Headquarters
Figure 4.5 Modular Facility Manufacturers: Distribution by Company Size and Location of Headquarters
Figure 4.6 Modular Facility Manufacturers: Distribution by Type of Industry Served
Figure 4.7 Modular Facility Manufacturers: Distribution by Geographical Coverage
Figure 4.8 Modular Facility Manufacturers: Distribution by Type of Industry Served and Geographical Coverage
Figure 4.9 Modular Facility Manufacturers: Distribution by GMP Compliance
Figure 4.10 Modular Facility Manufacturers: Distribution by Geographical Coverage and GMP Compliance
Figure 4.11 Modular Facility Manufacturers: Distribution by Type of Modular Construction
Figure 4.12 Modular Facility Manufacturers: Distribution by Type of Industry Served and Type of Modular Construction
Figure 4.13 Modular Facility Manufacturers: Distribution by Type of Material Used
Figure 4.14 Modular Facility Manufacturers: Distribution by Type of Modular Construction and Type of Material Used
Figure 4.15 Modular Facility Manufacturers: Distribution by Company Size, Geographical Coverage and Type of Industry Served
Figure 5.1 Modular Cleanroom Manufacturers: Distribution by Year of Establishment
Figure 5.2 Modular Cleanroom Manufacturers: Distribution by Company Size
Figure 5.3 Modular Cleanroom Manufacturers: Distribution by Location of Headquarters
Figure 5.4 Modular Cleanroom Manufacturers: Distribution by Year of Establishment and Location of Headquarters
Figure 5.5 Modular Cleanroom Manufacturers: Distribution by Company Size and Location of Headquarters
Figure 5.6 Modular Cleanroom Manufacturers: Distribution by Type of Industry Served
Figure 5.7 Modular Cleanroom Manufacturers: Distribution by Type of Industry Served and Location of Headquarters
Figure 5.8 Modular Cleanroom Manufacturers: Distribution by Type of Modular Cleanroom Offered
Figure 5.9 Modular Cleanroom Manufacturers: Distribution by Type of Industry Served and Type of Modular Cleanroom Offered
Figure 5.10 Modular Cleanroom Manufacturers: Distribution by Type of Cleanroom Component Offered
Figure 5.11 Modular Cleanroom Manufacturers: Distribution by Type of Industry Served and Cleanroom Component Offered
Figure 5.12 Modular Cleanroom Manufacturers: Distribution by Type of Modular Cleanroom and Cleanroom Component Offered
Figure 5.13 Modular Cleanroom Manufacturers: Distribution by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
Figure 5.14 Modular Cleanroom Manufacturers: Distribution by Quality Certifications Obtained
Figure 6.1 Company Competitiveness Analysis: Benchmarking of Service Strength
Figure 6.2 Company Competitiveness Analysis: Benchmarking of Partnership Activity
Figure 6.3 Company Competitiveness Analysis: Small Companies
Figure 6.4 Company Competitiveness Analysis: Mid-sized Companies
Figure 6.5 Company Competitiveness Analysis: Large Companies
Figure 7.1 Cytiva: Stages of KUBio Facility Project
Figure 7.2 Germfree: Types of Lab Modules
Figure 7.3 IPM Technologies: Features of ISOdule Units
Figure 7.4 IPM Technologies: Applications of Modular Facilities
Figure 7.5 KeyPlants: Modular Facility-related Services
Figure 7.6 NNE: Modular Facility-related Services
Figure 7.7 NNE: Benefits of Bio on Demand Facility
Figure 7.8 Pharmadule: Modular Facility Services
Figure 7.9 Pharmadule: Process of Modular Facility Construction
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2012-2022
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
Figure 8.4 Partnerships and Collaborations: Distribution by Type of Product
Figure 8.5 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
Figure 8.6 Partnerships and Collaborations: Distribution by Type of Modular Facility
Figure 8.7 Partnerships and Collaborations: Distribution by Type of Product and Type of Modular Facility
Figure 8.8 Most Active Players: Distribution by Number of Partnerships
Figure 8.9 Partnerships and Collaborations: Distribution by Location of Partner’s Headquarters
Figure 8.10 Partnerships and Collaborations: Distribution by Location of Modular Facility
Figure 8.11 Partnerships and Collaborations: Distribution by Type of Partnership and Location of Modular Facility
Figure 8.12 Partnerships and Collaborations: Distribution by Type of Product and Location of Modular Facility
Figure 8.13 Intercontinental and Intracontinental Partnerships
Figure 8.14 Partnerships and Collaborations: Country-wise Distribution
Figure 9.1 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Modular versus Conventional Construction Methods
Figure 9.2 Modular and Conventional Facilities: Comparison of Construction Timelines
Figure 9.3 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: KUBio Facility Construction Timeline
Figure 9.4 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Type of Modular Facility
Figure 9.5 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Size of Modular Facility
Figure 9.6 Most Active Manufacturers: Distribution by Number of Projects Delivered
Figure 9.7 Most Active Clients: Distribution by Number of Projects Received
Figure 9.8 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Location of Modular Facility
Figure 9.9 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Type of Facility and Size of Modular Facility
Figure 10.1 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Number of Facilities Delivered
Figure 10.2 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility
Figure 10.3 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility
Figure 10.4 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Purpose of Facility
Figure 10.5 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Investment
Figure 10.6 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility and Type of Investment
Figure 10.7 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Size of Facility
Figure 10.8 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Size of Facility
Figure 10.9 Facility Construction Trends in the Pharmaceutical Industry: Purpose of Facility and Size of Facility
Figure 10.10 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Headquarters
Figure 10.11 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Facility
Figure 10.12 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Location of Facility
Figure 11.1 Cost, Time Optimization Framework: Impact of Type of Material
Figure 11.2 Cost, Time Optimization Framework: Impact of Type of Modular Construction
Figure 11.3 Cost, Time Optimization Framework: Impact of Purpose of Facility
Figure 11.4 Cost, Time Optimization Framework: Impact of Geographical Location
Figure 11.5 Integrated Outcome Modeling – Scenario Analysis
Figure 11.5 Integrated Outcome Modeling – Output Analysis
Figure 12.1 Global Modular Construction Market in the Pharmaceutical / Biotechnology Industry, 2023-2035 (USD Million)
Figure 12.2 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Size of Facility, 2023 and 2035
Figure 12.3 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Small Facilities, 2023-2035 (USD Million)
Figure 12.4 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mid-sized Facilities, 2023-2035 (USD Million)
Figure 12.5 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Large Facilities, 2023-2035 (USD Million)
Figure 12.6 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Very Large Facilities, 2023-2035 (USD Million)
Figure 12.7 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Industry Served, 2023 and 2035
Figure 12.8 Modular Construction Market in the Pharmaceutical Industry, 2023-2035 (USD Million)
Figure 12.9 Modular Construction Market in the Biotechnology Industry, 2023-2035 (USD Million)
Figure 12.10 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Modular Construct, 2023 and 2035
Figure 12.11 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Hybrid Skid Modular Constructs, 2023-2035 (USD Million)
Figure 12.12 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Skid-Mounted Modular Constructs, 2023-2035 (USD Million)
Figure 12.13 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Plug-and-Play Modular Constructs, 2023-2035 (USD Million)
Figure 12.14 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Truckable Modular Constructs, 2023-2035 (USD Million)
Figure 12.15 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Modular Constructs, 2023-2035 (USD Million)
Figure 12.16 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Construction Component, 2023 and 2035
Figure 12.17 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Equipment, 2023-2035 (USD Million)
Figure 12.18 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Base Building, 2023-2035 (USD Million)
Figure 12.19 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mechanical, Electrical and Plumbing System, 2023-2035 (USD Million)
Figure 12.20 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Commodities, 2023-2035 (USD Million)
Figure 12.21 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Construction Components, 2023-2035 (USD Million)
Figure 12.22 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Purpose of Facility, 2023 and 2035
Figure 12.23 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Manufacturing Facilities, 2023-2035 (USD Million)
Figure 12.24 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Aseptic Filling Facilities, 2023-2035 (USD Million)
Figure 12.25 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Research and Development Facilities, 2023-2035 (USD Million)
Figure 12.26. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Facilities, 2023-2035 (USD Million)
Figure 12.27 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Scale of Operation, 2023 and 2035
Figure 12.28 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Clinical Operations, 2023-2035 (USD Million)
Figure 12.29 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Commercial Operations, 2023-2035 (USD Million)
Figure 12.30 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Product, 2023 and 2035
Figure 12.31 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Cell and Gene Therapies, 2023-2035 (USD Million)
Figure 12.32 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Vaccines, 2023-2035 (USD Million)
Figure 12.33 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Biosimilars, 2023-2035 (USD Million)
Figure 12.34 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Monoclonal Antibodies, 2023-2035 (USD Million)
Figure 12.35 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Advanced Pharmaceuticals, 2023-2035 (USD Million)
Figure 12.36 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Sterile Products, 2023-2035 (USD Million)
Figure 12.37 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Viral Vectors, 2023-2035 (USD Million)
Figure 12.38 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Products, 2023-2035 (USD Million)
Figure 12.39 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Facility, 2023 and 2035
Figure 12.40 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for New Facilities, 2023-2035 (USD Million)
Figure 12.41 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Facility Expansions, 2023-2035 (USD Million)
Figure 12.42 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Planned Expansions, 2023-2035 (USD Million)
Figure 12.43 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Modular Construction, 2023 and 2035
Figure 12.44 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Relocatable Modular Construction, 2023-2035 (USD Million)
Figure 12.45 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Permanent Modular Construction, 2023-2035 (USD Million)
Figure 12.46 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Material Used, 2023 and 2035
Figure 12.47 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Steel, 2023-2035 (USD Million)
Figure 12.48 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Wood, 2023-2035 (USD Million)
Figure 12.49 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Concrete, 2023-2035 (USD Million)
Figure 12.50 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Geography, 2023 and 2035
Figure 12.51 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in North America, 2023-2035 (USD Million)
Figure 12.52 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Europe, 2023-2035 (USD Million)
Figure 12.53 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Asia, 2023-2035 (USD Million)
Figure 12.54 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Middle East and North Africa, 2023-2035 (USD Million)
Figure 12.55 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Rest of the World, 2023-2035 (USD Million)
Figure 14.1 Modular Construction Market: Future Growth Opportunities
Figure 15.1 Concluding Remarks: Modular Facility Manufacturers Market Landscape
Figure 15.2 Concluding Remarks: Company Competitiveness Analysis
Figure 15.3 Concluding Remarks: Partnerships and Collaborations
Figure 15.4 Concluding Remarks: Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry
Figure 15.5 Concluding Remarks: Facility Construction Trends in Pharmaceutical Industry
Figure 15.6 Concluding Remarks: Market Forecast
Table 3.1 Cleanroom Classification Standards
Table 3.2 ISO and FED STD 209E: Cleanroom Classification
Table 4.1 Modular Facility Manufacturers: List of Service Providers
Table 4.2 Modular Facility Manufacturers: Information on Type of Industry Served, GMP Compliance and Geographical Coverage
Table 4.3 Modular Facility Manufacturers: Information on Type of Modular Construction and Type of Material Used
Table 4.4 Modular Facility Manufacturers: List of Quality Certifications Obtained
Table 5.1 Modular Cleanroom Manufacturers: List of Companies
Table 5.2 Modular Cleanroom Manufacturers: Type of Industry Served
Table 5.3 Modular Cleanroom Manufacturers: Type of Modular Cleanroom Offered
Table 5.4 Modular Cleanroom Manufacturers: Type of Cleanroom Component Offered
Table 5.5 Modular Cleanroom Manufacturers: List of Regulatory Approvals and Certifications Obtained
Table 6.1 Company Competitiveness Analysis: Benchmarking of Service Strength
Table 6.2 Company Competitiveness Analysis: Benchmarking of Partnership Activity
Table 6.3 Company Competitiveness Analysis: List of Small players
Table 6.4 Company Competitiveness Analysis: List of Mid-sized players
Table 6.5 Company Competitiveness Analysis: List of Large players
Table 7.1 List of Companies Profiled
Table 7.2 Cytiva: Key Highlights
Table 7.3 Cytiva: Modular Facility-Related Services
Table 7.4 Cytiva: Single-Use Technology Portfolio
Table 7.5 Cytiva: Modular Projects
Table 7.6 Cytiva: Recent Developments and Future Outlook
Table 7.7 G-Con Manufacturing: Key Highlights
Table 7.8 G-Con Manufacturing: Modular Facility-Related Services
Table 7.9 G-Con Manufacturing: Modular Projects
Table 7.10 G-Con Manufacturing: Recent Developments and Future Outlook
Table 7.11 Germfree: Key Highlights
Table 7.12 Germfree: Modular Facility-Related Services
Table 7.13 Germfree: Key Features of Modules
Table 7.14 Germfree: Recent Developments and Future Outlook
Table 7.15 IPM Technologies: Key Highlights
Table 7.16 IPM Technologies: Types of Modular Production Units
Table 7.17 KeyPlants: Key Highlights
Table 7.18 KeyPlants: Recent Developments and Future Outlook
Table 7.19 ModuleCo Pharma: Key Highlights
Table 7.20 ModuleCo Pharma: Key Features of Modular Facilities
Table 7.21 NNE: Key Highlights
Table 7.22 NNE: Modular Projects
Table 7.23 NNE: Recent Developments and Future Outlook
Table 7.24 Pharmadule: Key Highlights
Table 7.25 Pharmadule: Modular Projects
Table 7.26 Pharmadule: Recent Developments and Future Outlook
Table 8.1 Modular Facility Manufacturers: List of Partnerships and Collaborations, 2012-2022
Table 8.2 Modular Facility Manufacturers: List of Partnerships and Collaborations, Information on Type of Agreement 2012-2022
Table 9.1 Modular Facilities and Conventional Facilities: Comparison of Construction Investment and Financial Returns
Table 9.2 Modular Facilities: List of Modular Projects
Table 9.3 Modular Facilities: List of Clients and Location of Facility
Table 10.1 Conventional Facilities: Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry (Top 20 Companies): Historical Data, January 2016-2022
Table 10.2 Conventional Facilities: Information on Location of Headquarters, Area of Facility and Size of Facility
Table 13.1 Modular Facilities: Technological Advancements
Table 16.1 Avon Modular: Company Snapshot
Table 16.2. Environmental Systems Corporation: Company Snapshot
Table 16.3 Exyte: Company Snapshot
Table 16.4 G-Con Manufacturing: Company Snapshot
Table 16.5 Modular Devices: Company Snapshot
Table 16.6 ModWave: Company Snapshot
Table 16.7 Subzero Simplex Cleanrooms: Company Snapshot
Table 16.8 Vernick Cleanroom Design and Construction: Company Snapshot
Table 16.9 Zeton: Company Snapshot
Table 17.1 Modular Facility Manufacturers: Distribution by Year of Establishment
Table 17.2 Modular Facility Manufacturers: Distribution by Company Size
Table 17.3 Modular Facility Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 17.4 Modular Facility Manufacturers: Distribution by Location of Headquarters (Country-wise)
Table 17.5 Modular Facility Manufacturers: Distribution by Year of Establishment and Location of Headquarters
Table 17.6 Modular Facility Manufacturers: Distribution by Company Size and Location of Headquarters
Table 17.7 Modular Facility Manufacturers: Distribution by Type of Industry Served
Table 17.8 Modular Facility Manufacturers: Distribution by Geographical Coverage
Table 17.9 Modular Facility Manufacturers: Distribution by Type of Industry Served and Geographical Coverage
Table 17.10 Modular Facility Manufacturers: Distribution by GMP Compliance
Table 17.11 Modular Facility Manufacturers: Distribution by Geographical Coverage and GMP Compliance
Table 17.12 Modular Facility Manufacturers: Distribution by Type of Modular Construction
Table 17.13 Modular Facility Manufacturers: Distribution by Type of Industry Served and Type of Modular Construction
Table 17.14 Modular Facility Manufacturers: Distribution by Type of Material Used
Table 17.15 Modular Facility Manufacturers: Distribution by Type of Modular Construction and Type of Material Used
Table 17.16 Modular Facility Manufacturers: Distribution by Company Size, Geographical Coverage and Type of Industry Served
Table 17.17 Modular Cleanroom Manufacturers: Distribution by Year of Establishment
Table 17.18 Modular Cleanroom Manufacturers: Distribution by Company Size
Table 17.19 Modular Cleanroom Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 17.20 Modular Cleanroom Manufacturers: Distribution by Location of Headquarters (Country-wise)
Table 17.21 Modular Cleanroom Manufacturers: Distribution by Year of Establishment and Location of Headquarters
Table 17.22 Modular Cleanroom Manufacturers: Distribution by Company Size and Location of Headquarters
Table 17.23 Modular Cleanroom Manufacturers: Distribution by Type of Industry Served
Table 17.24 Modular Cleanroom Manufacturers: Distribution by Type of Industry Served and Location of Headquarters
Table 17.25 Modular Cleanroom Manufacturers: Distribution by Type of Modular Cleanroom Offered
Table 17.26 Modular Cleanroom Manufacturers: Distribution by Type of Industry Served and Type of Modular Cleanroom Offered
Table 17.27 Modular Cleanroom Manufacturers: Distribution by Type of Cleanroom Component Offered
Table 17.28 Modular Cleanroom Manufacturers: Distribution by Type of Industry Served and Cleanroom Component Offered
Table 17.29 Modular Cleanroom Manufacturers: Distribution by Type of Modular Cleanroom and Cleanroom Component Offered
Table 17.30 Modular Cleanroom Manufacturers: Distribution by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
Table 17.31 Modular Cleanroom Manufacturers: Distribution by Quality Certifications Obtained
Table 17.32 Partnerships and Collaborations: Cumulative Year-wise Trend, 2012-2022
Table 17.33 Partnerships and Collaborations: Distribution by Type of Partnership
Table 17.34 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
Table 17.35 Partnerships and Collaborations: Distribution by Type of Product
Table 17.36 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
Table 17.37 Partnerships and Collaborations: Distribution by Type of Modular Facility
Table 17.38 Partnerships and Collaborations: Distribution by Type of Product and Type of Modular Facility
Table 17.39 Most Active Players: Distribution by Number of Partnerships
Table 17.40 Partnerships and Collaborations: Distribution by Location of Partner’s Headquarters
Table 17.41 Partnerships and Collaborations: Distribution by Location of Modular Facility
Table 17.42 Partnerships and Collaborations: Distribution by Type of Partnership and Location of Modular Facility
Table 17.43 Partnerships and Collaborations: Distribution by Type of Product and Location of Modular Facility
Table 17.44 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Table 17.45 Partnerships and Collaborations: Location of Headquarters (Country-wise) Distribution
Table 17.46 Modular Facilities: Distribution by Type of Modular Facility
Table 17.47 Modular Facilities: Distribution by Size of Facility
Table 17.48 Most Active Manufacturers: Distribution by Number of Projects Delivered
Table 17.49 Most Active Clients: Distribution by Number of Projects Received
Table 17.50 Modular Facilities: Distribution by Location of Modular Facility
Table 17.51 Modular Facilities: Distribution by Type of Facility and Size of Modular Facility
Table 17.52 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Number of Facilities Delivered
Table 17.53 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility
Table 17.54 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility
Table 17.55 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Purpose of Facility
Table 17.56 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Investment
Table 17.57 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility and Type of Investment
Table 17.58 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Size of Facility
Table 17.59 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Size of Facility
Table 17.60 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility and Size of Facility
Table 17.61 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Headquarters
Table 17.62 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Facility
Table 17.63 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Location of Facility
Table 17.64 Global Modular Construction Market in the Pharmaceutical / Biotechnology Industry, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 17.65 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Size of Facility, 2023 and 2035
Table 17.66 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Small Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.67 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mid-sized Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.68 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Large Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.69 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Very Large Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.70 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Industry Served, 2023 and 2035
Table 17.71 Modular Construction Market in the Pharmaceutical Industry, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.72 Modular Construction Market in the Biotechnology Industry, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.73 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Modular Construct, 2023 and 2035
Table 17.74 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Hybrid Skid Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.75 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Skid-Mounted Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.76 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Plug-and-Play Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.77 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Truckable Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.78 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.79 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Construction Component, 2023 and 2035
Table 17.80 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Equipment, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.81 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Base Building, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.82 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mechanical, Electrical and Plumbing System, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.83 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Commodities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.84 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Construction Components, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.85 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Purpose of Facility, 2023 and 2035
Table 17.86 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Manufacturing Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.87 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Aseptic Filling Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.88 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Research and Development Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.89 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Facilities, 2023-2035, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.90 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Scale of Operation, 2023 and 2035
Table 17.91 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Clinical Operations, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.92 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Commercial Operations, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.93 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Product, 2023 and 2035
Table 17.94 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Cell and Gene Therapies, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.95 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Vaccines, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.96 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Biosimilars, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.97 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Monoclonal Antibodies, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.98 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Advanced Pharmaceuticals, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.99 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Sterile Products, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.100 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Viral Vectors, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.101 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Products, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.102 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Expansion, 2023 and 2035
Table 17.103 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for New Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.104 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Facility Expansions, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.105 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Planned Expansions, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.106 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Modular Construction, 2023 and 2035
Table 17.107 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Relocatable Modular Construction, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.108 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Permanent Modular Construction, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.109 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Material Used, 2023 and 2035
Table 17.110 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Steel, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.111 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Wood, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.112 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Concrete, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.113 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Geography, 2023 and 2035
Table 17.114 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in North America, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.115 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Europe, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.116 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Asia, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.117 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Middle East and North Africa, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.118 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Rest of the World, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
The following companies and organizations have been mentioned in the report:
Source 1: https://www.sciencedirect.com/topics/engineering/modular-construction
Source 2: https://www.pall.co.in/en/biotech/blog/modular-biomanufacturing.html